Research Blog

Hyperbaric oxygen therapy—a new hope for Alzheimer’s patients: a case report and literature review

Case report of self-initiated HBOT in a 62-year-old man with a clinical diagnosis of probable Alzheimer’s disease. He had over 400 HBOT sessions [2–3 times weekly, with a duration of 30–50 min, in a multi-place hyperbaric chamber at 2 atmospheres absolute (ATA)] over 7 years and use of donepezil (10 mg daily) for the last 3 years when formally diagnosed by the National Health Service (NHS) Memory Service. The patient’s longitudinal neurocognitive and neuroradiological evidence over 7 years of follow-up remained stable (with no major cognitive decline and no behavioral changes)

Read More

Hyperbaric Oxygen Therapy: USF’s Grant Sparks Breakthroughs in Medical Research

Through a grant from the Florida Legislature with an initial allocation of $14 million, USF Health researchers will conduct a clinical trial to study the efficacy of HBOT on individuals with symptoms after a traumatic brain injury (TBI) with or without symptoms of post-traumatic stress disorder (PTSD). This study seeks to clarify if HBOT will help individuals recover after TBI.

Read More

A-ListLifestyle Interview - Why the Celebs love HBOT

Ovidu gives a nice explanation of why HBOT works for our body, why doing HBOT for a period of time and then stopping for a week or so actually enhances the effectiveness of oxygen, and finally, why HBOT is effective for athletes and why working out, under pressure, inside your chamber can help you work out longer.

Read More